137 related articles for article (PubMed ID: 21854764)
1. Effect of dilution on high-density lipoprotein associated paraoxonase-1 activity.
Mackness M; Mackness B
Clin Biochem; 2011 Oct; 44(14-15):1270-1. PubMed ID: 21854764
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
3. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
5. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
James RW; Deakin SP
Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
[TBL] [Abstract][Full Text] [Related]
6. Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats.
Trudel K; Sinnett D; James RW; Delvin E; Amre D; Seidman E; Levy E
J Cell Biochem; 2005 Oct; 96(2):404-11. PubMed ID: 16052486
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
8. Effect of dietary lipids on paraoxonase-1 activity and gene expression.
Ferretti G; Bacchetti T
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
[TBL] [Abstract][Full Text] [Related]
10. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
Li C; Gu Q
Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
[TBL] [Abstract][Full Text] [Related]
13. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
14. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.
Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM
Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602
[TBL] [Abstract][Full Text] [Related]
15. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery.
Wysocka A; Cybulski M; Berbeć H; Wysokiński A; Stążka J; Daniluk J; Zapolski T
BMC Cardiovasc Disord; 2017 Apr; 17(1):92. PubMed ID: 28376720
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.
Rumora L; Rajković MG; Kopčinović LM; Pancirov D; Čepelak I; Grubišić TŽ
COPD; 2014 Sep; 11(5):539-45. PubMed ID: 24831724
[TBL] [Abstract][Full Text] [Related]
18. Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.
Noto H; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
Biochem Biophys Res Commun; 2001 Nov; 289(2):395-401. PubMed ID: 11716486
[TBL] [Abstract][Full Text] [Related]
19. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
Rozenberg O; Aviram M
Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
[TBL] [Abstract][Full Text] [Related]
20. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
